Advertisement
Advertisement

FTRE

FTRE logo

Fortrea Holdings Inc. Common Stock

16.80
USD
Sponsored
-0.25
-1.45%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

16.86

+0.06
+0.37%

FTRE Earnings Reports

Positive Surprise Ratio

FTRE beat 3 of 9 last estimates.

33%

Next Report

Date of Next Report
Feb 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
$678.53M
/
$0.16
Implied change from Q3 25 (Revenue/ EPS)
-3.25%
/
+33.33%
Implied change from Q4 24 (Revenue/ EPS)
-2.65%
/
-11.11%

Fortrea Holdings Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, FTRE reported earnings of 0.12 USD per share (EPS) for Q3 25, missing the estimate of 0.15 USD, resulting in a -21.52% surprise. Revenue reached 701.30 million, compared to an expected 660.69 million, with a 6.15% difference. The market reacted with a +23.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of 0.16 USD, with revenue projected to reach 678.53 million USD, implying an increase of 33.33% EPS, and decrease of -3.25% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Fortrea Holdings Inc. Common Stock reported EPS of $0.12, missing estimates by -21.52%, and revenue of $701.30M, 6.15% above expectations.
The stock price moved up 23.2%, changed from $9.70 before the earnings release to $11.95 the day after.
The next earning report is scheduled for Feb 26, 2026.
Based on 12 analysts, Fortrea Holdings Inc. Common Stock is expected to report EPS of $0.16 and revenue of $678.53M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement